Abstract
Background: Leukoencephalopathy (LEP) is a type of disease producing a variety of neurologic disturbances, the most prominent of which is dementia. The aim of the present study is to test the modulatory effect of sinapic acid against toluene induced dementia of LEP type in rats.
Materials and Methods: The study was designed to induce dementia by inhalation of toluene vapours (0.7% in air for 15 min.) for a period of 14 days in rats and then divided among different groups, i.e. Treatment group, negative control and two groups of sinapic acid, (at a dose of 20 and 40mg/kg, p.o.). These groups were treated and observed until the 28th day of experimental trial. The avoidance/escape behaviour was measured via Pole Climbing Apparatus; spatial memory was measured via Morris Water Maze, and locomotion was measured via photoactometer (beam breaks). The behavioral, Neuronal and biochemical parameters were determined. The estimation of Monoamine Oxidase (MAO-A, MAO-B), TNF-α, Acetylcholine esterase Enzyme and various antioxidant enzymes (GSH, TBARS, Nitrite, Catalase) was done by methods available in literature. Histological changes in the brain were also observed.
Result: Rats receiving 40 mg/kg of sinapic acid showed a significant therapeutic activity against toluene induced dementia of LEP type in rats.
Conclusion: From the present experimental findings, it has been concluded that a dose of 40 mg/kg, (p.o.) of sinapic acid provides better neuromodulation in neurons against toluene induced dementia of LEP type in rats with a better choice of drug.
Keywords: Toluene induced dementia, sinapic acid, pharmacological, leukoencephalopathy, histopathological study, spatial memory.
Graphical Abstract
The Natural Products Journal
Title:Modulatory Effect of Sinapic Acid in Toluene Induced Dementia of Leukoencephalopathy Type in Wistar Rats: a Biochemical Study
Volume: 8 Issue: 2
Author(s): Souravh Bais*Renu Kumari
Affiliation:
- Department of Pharmacology, Rayat Institute of Pharmacy, Railmajra,India
Keywords: Toluene induced dementia, sinapic acid, pharmacological, leukoencephalopathy, histopathological study, spatial memory.
Abstract: Background: Leukoencephalopathy (LEP) is a type of disease producing a variety of neurologic disturbances, the most prominent of which is dementia. The aim of the present study is to test the modulatory effect of sinapic acid against toluene induced dementia of LEP type in rats.
Materials and Methods: The study was designed to induce dementia by inhalation of toluene vapours (0.7% in air for 15 min.) for a period of 14 days in rats and then divided among different groups, i.e. Treatment group, negative control and two groups of sinapic acid, (at a dose of 20 and 40mg/kg, p.o.). These groups were treated and observed until the 28th day of experimental trial. The avoidance/escape behaviour was measured via Pole Climbing Apparatus; spatial memory was measured via Morris Water Maze, and locomotion was measured via photoactometer (beam breaks). The behavioral, Neuronal and biochemical parameters were determined. The estimation of Monoamine Oxidase (MAO-A, MAO-B), TNF-α, Acetylcholine esterase Enzyme and various antioxidant enzymes (GSH, TBARS, Nitrite, Catalase) was done by methods available in literature. Histological changes in the brain were also observed.
Result: Rats receiving 40 mg/kg of sinapic acid showed a significant therapeutic activity against toluene induced dementia of LEP type in rats.
Conclusion: From the present experimental findings, it has been concluded that a dose of 40 mg/kg, (p.o.) of sinapic acid provides better neuromodulation in neurons against toluene induced dementia of LEP type in rats with a better choice of drug.
Export Options
About this article
Cite this article as:
Bais Souravh *, Kumari Renu , Modulatory Effect of Sinapic Acid in Toluene Induced Dementia of Leukoencephalopathy Type in Wistar Rats: a Biochemical Study, The Natural Products Journal 2018; 8 (2) . https://dx.doi.org/10.2174/1570180815666171229154820
DOI https://dx.doi.org/10.2174/1570180815666171229154820 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Posterior Reversible Encephalopathy Syndrome with Atypical Presentation: A Pictorial Review on MR Imaging Features
Current Medical Imaging Neuropathological Correlates of Cerebral Multimorbidity
Current Alzheimer Research LFA-1 on Leukemic Cells as a Target for Therapy or Drug Delivery
Current Pharmaceutical Design Monoclonal Antibodies: A Target Therapy for Multiple Sclerosis
Inflammation & Allergy - Drug Targets (Discontinued) Azathioprine in Multiple Sclerosis
Mini-Reviews in Medicinal Chemistry The Changing Face of HIV/AIDS in Treated Patients
Current HIV Research HIV-Infected Patients and Liver Transplantation: Who, When and Why
Current HIV Research Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment
Current Cancer Therapy Reviews Diagnosis, Treatment, and New Developments in Preeclampsia
Current Women`s Health Reviews The Blood Brain Barrier, Mechanisms of Cerebral Edema, and the Use of Anti-Inflammatory and other Anti-Edema Agents in Neuro-Oncology
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Biologics for ANCA-Associated Vasculitis
Inflammation & Allergy - Drug Targets (Discontinued) Non-Celiac Gluten Sensitivity Triggers Gut Dysbiosis, Neuroinflammation, Gut-Brain Axis Dysfunction, and Vulnerability for Dementia
CNS & Neurological Disorders - Drug Targets Monoclonal Antibodies in Rare Acquired Thrombotic Disorders: The Paradigms of Paroxysmal Nocturnal Hemoglobinuria, Thrombotic Thrombocytopenic Purpura and Central Retinal Vein Occlusion
Current Vascular Pharmacology From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis
Current Neuropharmacology Nuclear Magnetic Resonance Spectroscopy and Genetic Disorders
Current Medicinal Chemistry Molecular Genetics of Early- and Late-Onset Alzheimer’s Disease
Current Gene Therapy Pharmacological Tools to Activate Microglia and their Possible use to Study Neural Network Patho-physiology
Current Neuropharmacology Targeting Neurotrophic Signal Transduction Pathways in the Treatment of Mood Disorders
Current Signal Transduction Therapy Toward The Rational Design of Cell Fate Modifiers Notch Signaling as a Target for Novel Biopharmaceuticals
Current Pharmaceutical Biotechnology Pathogens and Chronic or Long-Term Neurologic Disorders
Cardiovascular & Hematological Disorders-Drug Targets